Jun 1, 2026 07:00AM
Jun 1, 2026 07:00AM
May 12, 2026 04:05PM
May 11, 2026 07:00AM
May 11, 2026 07:00AM
Mar 24, 2026 04:01PM
Feb 26, 2026 07:02AM Fractyl Health completes enrollment in weight maintenance study
Feb 26, 2026 07:00AM
Jan 29, 2026 07:02AM
Jan 29, 2026 07:00AM
Jan 5, 2026 07:00AM
Dec 2, 2025 07:02AM
Dec 2, 2025 07:00AM
Nov 12, 2025 04:05PM Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027
Oct 7, 2025 07:02AM
Oct 7, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 3, 2025 07:00AM
Aug 12, 2025 04:05PM
Aug 6, 2025 08:30AM Fractyl Health prices $20 million public offering at $1.05 per share
Aug 6, 2025 08:30AM
Aug 5, 2025 04:15PM
Aug 5, 2025 04:15PM
Aug 5, 2025 04:04PM
Aug 5, 2025 04:02PM
Jun 23, 2025 07:41AM
Jun 23, 2025 07:40AM Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
Jun 23, 2025 07:30AM
Jun 18, 2025 07:03AM
Jun 18, 2025 07:00AM
Jun 4, 2025 07:00AM
May 19, 2025 07:08AM
May 19, 2025 07:00AM
May 17, 2025 07:15AM Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
May 13, 2025 04:05PM
Apr 1, 2025 07:00AM
Mar 3, 2025 04:05PM
Jan 31, 2025 08:01AM
Jan 13, 2025 07:00AM
Dec 12, 2024 07:00AM
Nov 12, 2024 04:05PM Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
Nov 4, 2024 04:05PM
Nov 4, 2024 07:00AM
Oct 28, 2024 07:00AM
Aug 14, 2024 04:05PM
Aug 8, 2024 08:00AM
Jul 30, 2024 07:02AM
Jul 30, 2024 07:00AM Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
Jun 25, 2024 07:00AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All